2018
DOI: 10.1016/j.bbrc.2017.11.058
|View full text |Cite
|
Sign up to set email alerts
|

Ascorbic acid attenuates endothelial permeability triggered by cell-free hemoglobin

Abstract: CFH increases endothelial permeability in part through depletion of intracellular ascorbate. Supplementation of ascorbate can attenuate increases in permeability mediated by CFH suggesting a possible therapeutic approach in sepsis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
38
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 45 publications
(42 citation statements)
references
References 29 publications
2
38
0
2
Order By: Relevance
“…13 Sera from GVHD patients induces expression of adhesion molecules VCAM-1, ICAM-1, and von Willebrand factor on in vitro endothelial cell cultures, suggesting an important link between endothelial dysfunction and alloreactive tissue injury. 14 Ascorbic acid applied in the clinical appropriate clinical settings attenuates endothelial dysfunction induced by provocations such as ischemia-reperfusion injury, 15,16 cell free hemoglobin, 17 and sepsis. 18,19 Ascorbic acid prevents reactive oxygen species generation through the NADPH oxidase, inducible NO synthase, and by reductive recycling of tetrahydrobiopterin.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…13 Sera from GVHD patients induces expression of adhesion molecules VCAM-1, ICAM-1, and von Willebrand factor on in vitro endothelial cell cultures, suggesting an important link between endothelial dysfunction and alloreactive tissue injury. 14 Ascorbic acid applied in the clinical appropriate clinical settings attenuates endothelial dysfunction induced by provocations such as ischemia-reperfusion injury, 15,16 cell free hemoglobin, 17 and sepsis. 18,19 Ascorbic acid prevents reactive oxygen species generation through the NADPH oxidase, inducible NO synthase, and by reductive recycling of tetrahydrobiopterin.…”
Section: Discussionmentioning
confidence: 99%
“…Ascorbic acid is an effective antiinflammatory agent with its demonstrated ability to inhibit NF-kB-driven inflammatory cytokines IL-6, IL-8, and TNF-a expression, and by its ability to enhance vasodilator nitric oxide (NO) production. 5,6 Further, hypovitaminosis C is well described in critically ill patients. In this population, intravenous ascorbic acid increases nitric oxide bioavailability in the microcirculation.…”
Section: Introductionmentioning
confidence: 99%
“…Ascorbic acid applied in the appropriate clinical settings attenuates endothelial dysfunction induced by provocations such as ischemia‐reperfusion injury, cell‐free hemoglobin, and sepsis . Ascorbic acid exerts a protective effect on vascular endothelium through several different pathways, including collagen synthesis, prevention of reactive oxygen species generation through the NADPH oxidase, inducible NO synthase and prevention of its scavenging by superoxide radicals, as well as by reductive recycling of tetrahydrobiopterin .…”
Section: Discussionmentioning
confidence: 99%
“…Ascorbic acid is an effective anti-inflammatory agent with its demonstrated ability to inhibit NF-kB-driven inflammatory cytokines IL-6, IL-8, and TNF-α expression, and by its ability to enhance vasodilator nitric oxide (NO) production. 5,6 Further, hypovitaminosis C is well described in critically ill patients, who have several parallels with HCT patients, such as, elevation of biomarkers including CRP and citrulline, as well as inflammatory cytokines such as TNFα, IL-1, and IL-6. [7][8][9][10] In this population, intravenous ascorbic acid increases nitric oxide bioavailability in the microcirculation.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation